New cannabis start-up enters market high with hopes

KwaZulu Natal-based start-up Tri-Medi Canna has partnered with UK-listed pharmaceutical company Apollon Formularies to open a cannabis production plant in SA. Tri-Medi Canna was established to focus on medical cannabis, a booming industry that the company said is forecast to be worth up to $7.1bn (R113.7bn) by 2023 in Africa with SA potentially making up 70% of the current market.

Related Keywords

South Africa ,Kwazulu ,Eastern Cape ,Natal , ,Tri Medi Canna ,United Kingdom Listed ,Apollon Formularies ,Sunday Times ,Business Day ,Financial Mail ,Napollon ,Sahpra ,Christopher Day ,Jamaica ,Euromonitor ,Cannabis ,Ari Nel Pharmacy Group ,Klabat ,European Union Good Manufacturing Processes ,Apollan ,Cannabis Master Plan ,Aquis Stock Exchange ,Angola ,The South African Health Products Regulatory Authority ,Labat South Africa ,Cilo Cybin ,Bandile Mkhize ,Reaking News ,Eneral ,Politics ,Port ,Entertainment ,Ifestyle ,Eird ,World ,Frica ,News ,Xtra ,Times ,He Times ,Usiness Times ,Shisa Live ,